Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2018-04-24 10:30 CEST (UTC+2h)
 

Calculation of Group effect for FDA studies [RSABE / ABEL]

posted by GM - India, 2017-06-09 08:10  - Posting: # 17473
Views: 1,631

Dear All,

What are necessary terms need to be used in ANOVA model, when the study conducted in cohorts (more than one group)...?

Every time I got confused with this.

Kindly suggest, any guidance is available.

Thanks in advance,
GM

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
18,206 posts in 3,871 threads, 1,156 registered users;
35 users online (1 registered, 34 guests).

Young man, in mathematics you don’t understand things.
You just get used to them.    John von Neumann

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed